• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测苯妥英钠剂量——一种修订的列线图。

Predicting phenytoin dose - a revised nomogram.

作者信息

Rambeck B, Boenigk H E, Dunlop A, Mullen P W, Wadsworth J, Richens A

出版信息

Ther Drug Monit. 1979;1(3):325-33. doi: 10.1097/00007691-197901030-00007.

DOI:10.1097/00007691-197901030-00007
PMID:555577
Abstract

The nomogram devised by Richens and Dunlop for predicting phenytoin dose has been tested in 127 residential epileptic patients, and the data obtained were used to prepare a revised version of the nomogram. In a further 78 patients, this new version was found to be superior to the original. The mean Km value was found to be 23.8 mumoles/liter. Km was independent of age and body surface area, but Dmax correlated positively with the latter two variables.

摘要

里琴斯和邓洛普设计的用于预测苯妥英剂量的列线图在127名住院癫痫患者中进行了测试,并将获得的数据用于编制列线图的修订版。在另外78名患者中,发现这个新版本优于原版。发现平均Km值为23.8微摩尔/升。Km与年龄和体表面积无关,但最大消除率(Dmax)与后两个变量呈正相关。

相似文献

1
Predicting phenytoin dose - a revised nomogram.预测苯妥英钠剂量——一种修订的列线图。
Ther Drug Monit. 1979;1(3):325-33. doi: 10.1097/00007691-197901030-00007.
2
Prediction of phenytoin dosage in relation to the variability of phenytoin plasma concentration.苯妥英钠剂量与苯妥英钠血浆浓度变异性的关系预测
Br J Clin Pharmacol. 1981 Jan;11(1):41-52. doi: 10.1111/j.1365-2125.1981.tb01100.x.
3
One-point feedback control method for phenytoin dosage adjustment.苯妥英钠剂量调整的单点反馈控制方法。
J Pharm Pharmacol. 1991 Jul;43(7):499-503. doi: 10.1111/j.2042-7158.1991.tb03522.x.
4
Individualization of phenytoin dosage regimens.
Clin Pharmacol Ther. 1977 Mar;21(3):287-93. doi: 10.1002/cpt1977213287.
5
Kinetics of intravenous phenytoin in children.
Pediatr Pharmacol (New York). 1984;4(1):31-8.
6
Therapeutic and pharmacokinetic effects of increasing phenytoin in chronic epileptics on multiple drug therapy.
Lancet. 1976 Aug 21;2(7982):386-9. doi: 10.1016/s0140-6736(76)92405-3.
7
[Rational phenytoin therapy: a method for individualizing dosage].[合理的苯妥英治疗:一种个体化给药剂量的方法]
Zhonghua Yi Xue Za Zhi. 1986 Mar;66(3):134-6, 188.
8
Letter: Phenytoin dosage nomogram.信函:苯妥英钠剂量图。
Lancet. 1975 Dec 27;2(7948):1305-6. doi: 10.1016/s0140-6736(75)90640-6.
9
Plasma levels of phenobarbital and phenytoin in epileptic outpatients.癫痫门诊患者的苯巴比妥和苯妥英血浆水平。
Eur Neurol. 1977;15(3):135-42. doi: 10.1159/000114802.
10
Serum-phenytoin levels in management of epilepsy.癫痫治疗中血清苯妥英水平
Lancet. 1975 Aug 9;2(7928):247-8. doi: 10.1016/s0140-6736(75)90962-9.

引用本文的文献

1
Management of refractory complex partial seizures: current state of the art.难治性复杂部分性发作的治疗:现状。
Neuropsychiatr Dis Treat. 2010 Jun 24;6:297-308. doi: 10.2147/ndt.s4489.
2
Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.抗癫痫药物治疗的优化。血清药物浓度监测的重要性。
Clin Pharmacokinet. 1996 Aug;31(2):120-30. doi: 10.2165/00003088-199631020-00004.
3
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
抗癫痫药物在儿科患者中的临床药代动力学。第二部分。苯妥英、卡马西平、舒噻美、拉莫三嗪、氨己烯酸、奥卡西平和非氨酯。
Clin Pharmacokinet. 1995 Nov;29(5):341-69. doi: 10.2165/00003088-199529050-00004.
4
Predicting individual phenytoin dosage.
J Pharmacokinet Biopharm. 1981 Apr;9(2):131-46. doi: 10.1007/BF01068078.
5
Prediction of phenytoin dosage in relation to the variability of phenytoin plasma concentration.苯妥英钠剂量与苯妥英钠血浆浓度变异性的关系预测
Br J Clin Pharmacol. 1981 Jan;11(1):41-52. doi: 10.1111/j.1365-2125.1981.tb01100.x.
6
Ethnic differences in drug metabolism.药物代谢中的种族差异。
Clin Pharmacokinet. 1982 Sep-Oct;7(5):373-400. doi: 10.2165/00003088-198207050-00001.
7
Phenytoin Michaelis-Menten pharmacokinetics in Caucasian paediatric patients.
Clin Pharmacokinet. 1983 Nov-Dec;8(6):545-9. doi: 10.2165/00003088-198308060-00006.
8
Steady-state pharmacokinetics of phenytoin from routinely collected patient data.
Clin Pharmacokinet. 1983 Jul-Aug;8(4):355-64. doi: 10.2165/00003088-198308040-00006.
9
Clinical application of the Mullen and Foster method for individualizing phenytoin dosage.
Ital J Neurol Sci. 1984 Jun;5(2):195-200. doi: 10.1007/BF02043223.
10
Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing.临床药代动力学:治疗药物监测与处方的综合系统。
Br Med J (Clin Res Ed). 1984 Feb 18;288(6416):541-5. doi: 10.1136/bmj.288.6416.541.